These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2013-001732-21 A randomized, double blind, placebo-controlled phase II study of metformin in myotonic dystrophy type 1 patients 2017-11-17 due-trials
Exempt 2018-000457-53 A phase 1/2, open-label, safety, tolerability and preliminary efficacy study of implantation into one eye of hESC-derived RPE (Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)) in p... not-yet-due
Other 2020-004594-43 AUDIOWOLF: A phase II, open-label, efficacy study of daily administration of sodium valproate in patients clinically affected by Wolfram syndrome due to monogenic mutation AUDIOWOLF: Estudio de efi... not-yet-due